Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04394624 |
| Title | Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04) (CARMEN-LC04) |
| Acronym | CARMEN-LC04 |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Sanofi |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ESP | CZE | BGR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Henry Ford Hospital Site Number : 8400005 | Detroit | Michigan | 48202 | United States | Details | |
| Roswell Park Cancer Institute Site Number : 8400003 | Buffalo | New York | 14263 | United States | Details | |
| McClinton Cancer Center Site Number : 8400002 | Waco | Texas | 76712 | United States | Details | |
| Investigational Site Number : 1000001 | Plovdiv | 4004 | Bulgaria | Details | ||
| Investigational Site Number : 2030001 | Ostrava - Vitkovice | 703 84 | Czechia | Details | ||
| Investigational Site Number : 2030002 | Praha 2 | 12808 | Czechia | Details | ||
| Investigational Site Number : 4100001 | Seoul | Seoul-teukbyeolsi | 03080 | Korea, Republic of | Details | |
| Investigational Site Number : 4100002 | Seoul | Seoul-teukbyeolsi | 03722 | Korea, Republic of | Details | |
| Investigational Site Number : 6200001 | Porto | 4200-162 | Portugal | Details | ||
| Investigational Site Number : 7240001 | Barcelona / Sabadell | Catalunya [Cataluña] | 08208 | Spain | Details | |
| Investigational Site Number : 7240005 | Madrid | Madrid, Comunidad De | 28046 | Spain | Details | |
| Investigational Site Number : 7240004 | Madrid | 28040 | Spain | Details | ||
| Investigational Site Number : 7240003 | Zaragoza | 50009 | Spain | Details |